N@N

Daniil Gataulin Maintained (ADVM) at Strong Buy with Increased Target to $40 on, Jul 18th, 2024

Daniil Gataulin of Chardan Capital, Maintained "Adverum Biotechnologies, Inc." (ADVM) at Strong Buy with Increased Target from $4 to $40 on, Jul 18th, 2024.

Daniil has made no other calls on ADVM in the last 4 months.

There are 5 other peers that have a rating on ADVM. Out of the 5 peers that are also analyzing ADVM, 1 agrees with Daniil's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Luca Issi of "RBC Capital" Maintained at Hold with Decreased Target to $20 on, Tuesday, March 19th, 2024

These are the ratings of the 4 analyists that currently disagree with Daniil

---

• Francois Brisebois of "Oppenheimer" Initiated at Buy and Held Target at $25 on, Tuesday, June 25th, 2024
• Joon Lee of "Truist Securities" Maintained at Strong Buy and Held Target at $60 on, Wednesday, May 15th, 2024
• Matthew Caufield of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $30 on, Friday, May 10th, 2024
• Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $22 on, Monday, April 29th, 2024